Nukui, A., Masuda, A., Abe, H., Arai, K., Yoshida, K., & Kamai, T. (2017). Increased serum level of soluble interleukin-2 receptor is associated with a worse response of metastatic clear cell renal cell carcinoma to interferon alpha and sequential VEGF-targeting therapy. BMC Cancer.

Nukui, Akinori, Akinori Masuda, Hideyuki Abe, Kyoko Arai, Ken-Ichiro Yoshida, och Takao Kamai. "Increased Serum Level of Soluble Interleukin-2 Receptor Is Associated With a Worse Response of Metastatic Clear Cell Renal Cell Carcinoma to Interferon Alpha and Sequential VEGF-targeting Therapy." BMC Cancer 2017.

Nukui, Akinori, et al. "Increased Serum Level of Soluble Interleukin-2 Receptor Is Associated With a Worse Response of Metastatic Clear Cell Renal Cell Carcinoma to Interferon Alpha and Sequential VEGF-targeting Therapy." BMC Cancer 2017.